This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Insider Roster
- Ivor Royston, 2024-11-27
- Roger Pomerantz, 2024-11-27
- Flavia Borellini, 2024-06-24
- Jane Chung, 2024-06-24
- Lafayette Samuel Murphy, 2024-06-24
- E Thomas Darcy, 2024-06-24
- J. Barry Simon, 2024-06-24
- F Jane Barlow, 2024-06-24
- Stephen Rubino, 2024-06-24
- E. Michael Faerm, Chief Financial Officer, 2024-05-16
- Melody Burcar, Senior Vp, Finance, 2024-03-22
- Mark Rothera, President and Ceo, 2024-03-14
- P. Darrel Cohen, Chief Medical Officer, 2024-03-14
- R. Daniel Chevallard, Cfo and Coo, 2024-03-14
- Lisa Rojkjaer, Chief Medical Officer, 2023-03-17
- Nicole Onetto, Director, 2022-06-10
- Michael Huang, Director, 2022-06-10
- Gur Roshwalb, Large Shareholder, Director, 2021-03-31
- Chaim Yair Schindel, Large Shareholder, 2021-02-25
- Partnership Limited Fund 2 Amoon, Large Shareholder, 2021-02-25
- S Parvinder Hyare, See Remarks, 2021-01-07
- Dayton Misfeldt, See Remarks, 2020-07-01
- L Homer Pearce, Director, 2020-07-01
- Ward Henry Wolff, Director, 2020-07-01
- W James Young, Director, 2020-07-01
- Steve Carchedi, Director, 2020-07-01
- B Steven Ketchum, Director, 2020-07-01
- C David Stump, Director, 2020-07-01
- Tina Gullotta, Vp, Finance, 2020-06-05
- P. William Quinn, See Remarks, 2020-04-02
- A. Judith Fox, See Remarks, 2020-04-02
- Aisling Capital Partners Iv, Lp, Large Shareholder, 2019-07-15
- Aisling Capital Partners Iv Llc, Large Shareholder, 2019-07-15
- Aisling Capital Iv, Lp, Large Shareholder, 2019-07-15
- Steve Elms, Large Shareholder, 2019-07-15
- N Andrew Schiff, Large Shareholder, 2019-07-15
- Mpm Oncology Impact Management Gp Llc, Large Shareholder, 2017-11-07
- L.p. Management (Cayman) Fund Impact Oncology, Large Shareholder, 2017-11-07
- L.p. Fund Impact Oncology Ubs, Large Shareholder, 2017-11-07
- Mpm Oncology Impact Management Lp, Large Shareholder, 2017-11-07
- Jr N Daniel Swisher, President and Ceo, 2017-07-12
- M. Geoffrey Parker, Director, 2017-06-02
- Eric Bjerkholt, Evp, Cfo & Corp. Secretary, 2016-12-07
- Matthew Fust, Director, 2016-07-05
- Bay City Capital Fund V, L.p., Large Shareholder, 2015-07-28
- Bay City Capital Llc, Large Shareholder, 2015-07-28
- Bay City Capital Fund V Co-Investment Fund, L.p., Large Shareholder, 2015-07-28
- Bay City Capital Management V Llc, Large Shareholder, 2015-07-28
- Susan Helen Kim, Director, 2015-07-02
- R Adam Craig, Evp, Development & Cmo, 2015-03-03
- J Peter Barris, Large Shareholder, 2014-08-29
- James M Barrett, Large Shareholder, 2014-08-29
- D Scott Sandell, Large Shareholder, 2014-08-29
- Kittu Krishna Kolluri, Large Shareholder, 2014-08-29
- J Patrick Kerins, Large Shareholder, 2014-08-29
- D Ryan Drant, Large Shareholder, 2014-08-29
- Forest Baskett, Large Shareholder, 2014-08-29
- Growth Equity Opportunities Fund, Llc, Large Shareholder, 2014-08-29
- New Enterprise Associates 12, Limited Partnership, Large Shareholder, 2014-08-29
- Nea Partners 12, Limited Partnership, Large Shareholder, 2014-08-29
- Nea 12 Gp, Llc, Large Shareholder, 2014-08-29
- I Joseph Depinto, Evp, Cco, 2014-03-05
- Edward Hurwitz, Director, 2013-07-02
- Alta Biopharma Partners Iii Gmbh & Co Beteiligungs Kg, Other, 2010-07-02
- Alta Embarcadero Biopharma Partners Iii Llc, Other, 2010-07-02
- Alta Biopharma Management Iii Llc, Other, 2010-07-02
- Alta Biopharma Partners Iii Lp, Other, 2010-07-02
- Edward Penhoet, Other, 2010-07-02
- Jean Deleage, Other, 2010-07-02
- Farah Champsi, Other, 2010-07-02
- W Mark Perry, Large Shareholder, 2010-07-02
- Richard C Kramlich, Large Shareholder, 2010-07-02
- Iii W Charles Newhall, Large Shareholder, 2010-07-02
- Dominique Semon, Large Shareholder, 2010-05-04
- Warburg Pincus Equity Partners Lp Warburg Pincus & Co Warbur, Large Shareholder, 2009-07-21
Show All Insiders (75) Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
| 1. | | 0 | $0 | | 0% |
| 2. | | 0 | $0 | | 0% |
| 3. | | 0 | $0 | | 0% |
| 4. | | 0 | $0 | | 0% |
| 5. | | 0 | $0 | | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Officer, Director | $0.49 | 47,906 | $23,627.24 | 100,000 | 2023-12-01 | Filing |
| Officer, Director | $0.49 | 52,094 | $25,734.44 | 52,094 | 2023-11-30 | Filing |
| Officer, Director | $5.56 | 8,000 | $44,480.00 | 548,599 | 2021-11-15 | Filing |
| Officer | $0.33 | 6,000 | $1,989.00 | 20,500 | 2020-05-29 | Filing |
| Officer | $0.37 | 6,000 | $2,193.00 | 127,697 | 2019-11-29 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Officer | $0.73 | 3,405 | $2,493.14 | 102,306 | 2024-02-27 | Filing |
| Officer | $0.50 | 3,720 | $1,860.00 | 98,822 | 2023-11-28 | Filing |
| Officer | $1.45 | 3,512 | $5,092.40 | 95,653 | 2023-08-28 | Filing |
| Officer | $1.42 | 3,635 | $5,160.25 | 92,277 | 2023-05-25 | Filing |
| Officer | $1.68 | 2,156 | $3,624.67 | 48,087 | 2023-02-27 | Filing |
Filing Period:
| No. | Name | Shares | Value | % Port |
| 1. | | 0 | $0 | 0% |
| 2. | | 0 | $0 | 0% |
| 3. | | 0 | $0 | 0% |
| 4. | | 0 | $0 | 0% |
| 5. | | 0 | $0 | 0% |